Remarkably, within the SOD1 mouse model, astrocytic NF-κB inhibition via both transgenic and viral IκB suppression was not sufficient to improve motor neuron survival or ALS progression, highlighting the role of microglial NF-κB in inducing ALS presentation [40,41]. The gene discussed is NFKB1; the disease is amyotrophic lateral sclerosis.